- Home
- JD vs GSK Comparison
JD vs GSK Comparison
Compare JD & GSK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JD
- GSK
- Stock Information
- Founded
- JD 2006
- GSK 1715
- Country
- JD China
- GSK United Kingdom
- Employees
- JD N/A
- GSK N/A
- Industry
- JD Other Specialty Stores
- GSK Biotechnology: Pharmaceutical Preparations
- Sector
- JD Consumer Discretionary
- GSK Health Care
- Exchange
- JD Nasdaq
- GSK Nasdaq
- Market Cap
- JD 62.3B
- GSK 74.6B
- IPO Year
- JD 2014
- GSK N/A
- Fundamental
- Price
- JD $41.12
- GSK $38.77
- Analyst Decision
- JD Strong Buy
- GSK Hold
- Analyst Count
- JD 12
- GSK 4
- Target Price
- JD $46.25
- GSK $47.00
- AVG Volume (30 Days)
- JD 14.2M
- GSK 4.7M
- Earning Date
- JD 03-06-2025
- GSK 04-30-2025
- Dividend Yield
- JD 2.38%
- GSK 4.00%
- EPS Growth
- JD 76.41
- GSK N/A
- EPS
- JD 3.68
- GSK 0.78
- Revenue
- JD $158,761,901,950.00
- GSK $39,280,393,592.00
- Revenue This Year
- JD $5.95
- GSK $7.60
- Revenue Next Year
- JD $5.49
- GSK $5.24
- P/E Ratio
- JD $11.17
- GSK $23.82
- Revenue Growth
- JD 6.84
- GSK 3.46
- 52 Week Low
- JD $24.13
- GSK $31.72
- 52 Week High
- JD $47.82
- GSK $45.93
- Technical
- Relative Strength Index (RSI)
- JD 47.06
- GSK 53.04
- Support Level
- JD $41.36
- GSK $37.76
- Resistance Level
- JD $43.38
- GSK $38.98
- Average True Range (ATR)
- JD 1.09
- GSK 0.53
- MACD
- JD -0.30
- GSK -0.24
- Stochastic Oscillator
- JD 24.46
- GSK 37.08
About JD JD.com Inc.
JD.com is the third-largest Chinese e-commerce platform by GMV in 2024. it offers a wide selection of authentic products with speedy and reliable delivery. The company has built its own nationwide fulfilment infrastructure and last-mile delivery network, staffed by its own employees, which supports both its online direct sales, its online marketplace and omnichannel businesses.
About GSK GSK plc (Each representing two)
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, antiviral, and vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.